A Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Effects of Esomeprazole 40 mg bid on the Signs and Symptoms of Chronic Posterior Laryngitis in Patients with Suspected Laryngopharyngeal Reflux
Study identifier:291
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Study Complete
Official Title
A Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Effects of Esomeprazole 40 mg bid on the Signs and Symptoms of Chronic Posterior Laryngitis in Patients with Suspected Laryngopharyngeal Reflux
Medical condition
gastrointestinal diseases
Phase
N/A
Healthy volunteers
-
Study drug
-
Sex
-
Actual Enrollment
-
Study type
Interventional
Age
-
Date
Study Start Date: 01 Jan 1971
Primary Completion Date: -
Study Completion Date: -
Study design
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verification:
Verified 01 Nov 2013 by AstraZeneca
Sponsors
AstraZeneca
Collaborators
-
Inclusion and exclusion criteria
Loading...
No locations available
| Arms | Assigned Interventions |
|---|
